Company / Current Liabilities per Share
NewAmsterdam Pharma Co N.V. Current Liabilities per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$2.37
FY2025
5-year range
$1.38 / $2.95
FY2022-FY2025
Trend
-19.8%
vs FY2024
Sector context
#63 of 210
Health Care
What the data says
At $2.37, NewAmsterdam Pharma Co N.V.'s current liabilities per share ranks #148 of 210 in the Health Care sector. Increased from $1.38 to $2.37 over the past 2 years.
Based on SEC 10-K filings.
2.37 in FY2025 with a 3-year CAGR of +7.6%.
Increased from $1.38 to $2.37 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +7.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#148 of 210 in Health CareTop 70% of 210This company $2.37 Sector average $23.79
▼
-90.1% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 19.8% year-over-year.
- Ranks #63 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.37 | -19.8% |
| FY2024 | $2.95 | +114.3% |
| FY2023 | $1.38 | -27.6% |
| FY2022 | $1.90 | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026